Overview

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Status:
Completed

Trial end date:
2004-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test feasibility, toxicity and efficacy of two different adjuvant treatment schedules in Stage II-IIIa Non-small cell lung cancer patients with positive lymph nodes.

Phase:

Phase 2

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Cisplatin
Gemcitabine